This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toyoshima, M. Articles by Tsuruo, T. Search for Related Content PubMed PubMed Citation Articles by Toyoshima, M. Articles by Tsuruo, T.

Purification and Characterization of the Platelet-Aggregating Sialoglycoprotein gp44 Expressed by Highly Metastatic Variant Cells of Mouse Colon Adenocarcinoma 26¹

Laboratory of Biomedical Research, Institute of Molecular and Cellular Bioscience, The University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113, [M. T., M. N., T. T.], and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 170 [T. Y., T. T.], Japan

A platelet-aggregating sialoglycoprotein with a molecular weight of 44,000 (gp44) was immunochemically purified from highly metastatic mouse adenocarcinoma cells. The rat monoclonal antibody (mAb) 8F11 used in the purification procedure has been generated previously against NL-17 cells derived from the mouse colon 26 cell line. mAb 8F11 inhibits NL-17 cells from inducing platelet aggregation and suppresses their experimental metastasis to the lung. The purified gp44 induced mouse platelet aggregation in a dose-dependent manner without any plasma component. This aggregation was completely inhibited by mAb 8F11. The gp44 was partially characterized by sequential enzymatic hydrolysis of carbohydrates and was found to be O-glycans enriched. When gp44 was sequentially treated with N-glycanase and neuraminidase, it lost platelet aggregation activity. Further treatment with O-glycanase resulted in a loss of the reactivity to mAb 8F11. These results suggest that sialylated carbohydrate chains of gp44 are involved in the induction of platelet aggregation and may play an important role in the colonization of NL-17 cells in the lung.

¹ This work was supported in part by grants from the Ministry of Education, Science and Culture, Japan, and Special Coordination Fund of the Science and Technology Agency, Japan.

² To whom requests for reprints should be addressed.

Received 8/22/94. Accepted 12/ 9/94.

This article has been cited by other articles:

				M. Kaneko, Y. Kato, A. Kunita, N. Fujita, T. Tsuruo, and M. Osawa Functional Sialylated O-Glycan to Platelet Aggregation on Aggrus (T1{alpha}/Podoplanin) Molecules Expressed in Chinese Hamster Ovary Cells J. Biol. Chem., September 10, 2004; 279(37): 38838 - 38843. [Abstract] [Full Text] [PDF]

				Y. Kato, N. Fujita, A. Kunita, S. Sato, M. Kaneko, M. Osawa, and T. Tsuruo Molecular Identification of Aggrus/T1{alpha} as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors J. Biol. Chem., December 19, 2003; 278(51): 51599 - 51605. [Abstract] [Full Text] [PDF]

				Y. J. Kim, L. Borsig, H.-L. Han, N. M. Varki, and A. Varki Distinct Selectin Ligands on Colon Carcinoma Mucins Can Mediate Pathological Interactions among Platelets, Leukocytes, and Endothelium Am. J. Pathol., August 1, 1999; 155(2): 461 - 472. [Abstract] [Full Text] [PDF]

				B. Nieswandt, M. Hafner, B. Echtenacher, and D. N. Mannel Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets Cancer Res., March 1, 1999; 59(6): 1295 - 1300. [Abstract] [Full Text] [PDF]

				Y. J. Kim, L. Borsig, N. M. Varki, and A. Varki P-selectin deficiency attenuates tumor growth and metastasis PNAS, August 4, 1998; 95(16): 9325 - 9330. [Abstract] [Full Text] [PDF]